
Vascular Biology 2025
Annual Meeting of NAVBO and the Microcirculatory Society
October 19-23, 2025
Cape Cod, Massachusetts
Keynote Lecture by Donald Ingber, Wyss Institute for Biologically Inspired Engineering at Harvard University
Vascular Biology 2025 – Preliminary Program | ||
Day 1 – Sunday, October 19 | ||
2:00-6:00pm | Pre-conference Meeting for Trainees (featured speaker, and program to be determined) Organizers: Yu Jung Shin, University of Washington and Xiaochen Fan, Stanford University | |
7:15-9:30pm | Judah Folkman Award in Vascular Biology Presentation and Lecture - TBD Earl P. Benditt Award Presentation and Lecture - TBD | |
9:30-10:30pm | Welcome Reception | |
Day 2 – Monday, October 20 | ||
7:00-8:00am | Group Breakfast | Networking 101 |
8:00-10:00am | Regenerative Medicine and Cardiovascular Repair Dynamic In vitro models of vascular growth and injury across scales Ying Zheng, University of Washington Delivery of a novel angiogenic cocktail in a customized hydrogel biomaterial improves revascularization and wound healing Kareen Coulombe, Brown University | Microvascular Dysfunction in Shock Extracelluar vesicles in vascular inflammation and barrier dysfunction vascular permeability during sepsis |
10:30am- 12:30pm | Vascular Remodeling in the Uterus and Placenta Impact of the regulation of uteroplacental perfusion on fetal growth, novel animal models and human studies Ramon Lorca, University of Colorado Mechanisms of placental & uterine vascular growth Mark Kahn, University of Pennsylvania | Inflammation in Small Vessels Vascular permeability, cause and consequence Lena Claesson-Welsh, Uppsala University Tracking neutrophil infiltration into the ischemic brain reveals new targets for treating stroke David Sullivan, Northwestern University |
12:00-1:45pm | Lunch and Learn for Trainees | Lunch for all others |
1:45-3:45pm | Plenary Session: Mechanosensing and Mechanotransduction in the Vasculature Flow-mediated endothelial cell signaling and vascular inflammation Julia Mack, University of California, Los Angeles Flow-induced reprogramming of endothelial cells in atherogenesis Hanjoong Jo, Emory University | |
4:00-5:00pm | Nano-talks | |
5:00-7:00pm | Dinner on your own | |
7:00-10:00pm | Poster Sessions | |
Day 3 – Tuesday, October 21 | ||
7:00-8:00am | Group Breakfast | Career Development Forum Breakfast |
8:00-10:00am | Vascular Extracellular Matrix Bioengineering Engineering human blood vessels for modeling and therapeutics Sharon Gerecht, Duke University Matrix-mediated regeneration of vasa vasorum as a treatment for aortic aneurysm Julie Phillippi, University of Pittsburgh | Neuroinflammation Mechanisms of cerebral microvascular dysfunction in AD/ADRD: role of cellular inflammatory mediators Paulo Pires, University of Arizona Vascular contributions to neuroinflammation: novel roles for endothelial tissue-nonspecific alkaline phosphatase Candice Brown, Indiana University School of Medicine |
10:30am-12:30pm | Advanced Molecular Mechanisms in Vascular Matrix Remodeling Systems approach to cardiovascular calcification Mineralization in the matrix | Epigenetic and Post-Transcriptional Control of the Vasculature Sex-specific epigenetic mechanisms in cerebrovascular injury Kahlilia Morris-Blanco, University of Pennsylvania Dynamic epigenetic signatures during vascular development Angie Serrano, Boston University |
12:30-1:30pm | Topical Panel Discussion with lunch | Group Lunch |
1:30-3:30pm | MCS President’s Symposium: Bone Marrow Niche Clonal hematopoiesis: the emergent risk factor Kenneth Walsh, University of Virginia TBD Miriam Cortese-Krott, Heinrich Heine University | |
3:30-4:15pm | MCS Landis Award Lecture Recipient to be determined | |
4:30-5:30pm | Emerging Topics in Microcirculation Presentations are chosen from abstracts | Blood Vascular Development Higd1b is a unique and conserved gene marker for pericytes Ke Yuan, Boston Children’s Hospital How do endothelial cells make adaptive decisions? Katie Bentley, Francis Crick Institute |
5:30-7:00pm | Dinner on your own | |
7:00-10:00pm | Poster Sessions | |
Day 4 – Wednesday, October 22 | ||
7:00-8:00 | Group Breakfast | Career Development Forum Breakfast |
8:00-10:00am | Lymphatic Vascular Development Chemokine signaling as a guiding cue regulating lymphatic development Xiaolei Liu, Temple University Mechanisms of lymphatic vessel and valve morphogenesis Joshua Scallan, University of South Florida | Innovations in Vascular Tissue Engineering Bioengineered perfused human brain microvasculature to model brain tumor and neurodegenerative diseases Guohao Dai, Northeastern University Delineating the role of vasculatrue in beta cell development and cell therapies for type 1 diabetes Yasaman Aghazadeh, University of Montreal |
10:30am- 12:30pm | Health Disparities and the Microcirculation Fission/fusion modulators of age-related coronary microvascular function The role of pluripotency and innate immunity in sex differences in endothelial cells | Metabolism and Vascular Dysfunction Immune metabolic reprogramming in vascular inflammation and salt-sensitive hypertension Evolving landscape of atherosclerosis in the COVID-19 era |
12:30-2:00pm | Topical Panel Discussion with lunch | Group Lunch |
2:00-3:00pm | Keynote Lecture New roles for endothelial cells and mechanical forces revealed using human organ chips | |
3:00-4:00pm | NAVBO – Award Lectures and Presentations (recipients to be determined) Presentation of the Stephen Schwartz Award Presentation of the Florence Sabin Award Springer Award Presentation and Lecture | |
4:15-5:15pm | Technology Workshop | |
5:00-7:00pm | Dinner on your own | |
7:00-10:00pm | Posters Sessions | |
Day 5 – Thursday, October 23 | ||
8:00-8:15am | Presentation of the Poster Awards | |
8:15-10:15pm | Plenary Session: Genetics in Vascular Inflammation Impact opopulation structure on genetic findings and polygenic risk scores: lessons learned from the locus 9p21 Gut microbiota-immune interactions modulating vascular inflammation in mice | |
10:45am-12:45pm | Plenary Session: Genetic Drivers of Vascular Malformations Pathogenic variants that activate RAS-MAPK signaling drive lymphatic anomalies Drug development for arteriovenous malformation | |
12:45-1:00pm | Closing Remarks |